Newsletter Article Provides Targeted Prevention Recommendations
ISMP Newsroom
Safe medication practices depend on communication within the healthcare community, including patients and their families. ISMP is at the forefront of medication error reporting and guidance on safe medication practices, and is often cited in the media as a reputable resource for current information and emerging trends. In 2020, ISMP formally affiliated with ECRI to create one of the largest quality and safety entities in the world. ISMP's Newsroom includes ISMP and ECRI news releases, as well as ISMP blog posts, statements, and other communications.
To schedule an interview or request to be added to ISMP’s news release distribution lists, contact Renee Brehio.
Recent Updates
Analysis of Flu Vaccine Error Reports Can Help Increase Safety
ISMP Survey Explores Best Practice Implementation, Safety Challenges
The Institute for Safe Medication Practices (ISMP) is proud to announce its 23rd Annual Cheers Awards winners.
Results Show Status of Best Practice Implementation and Technology Use
ECRI and ISMP speak up for patient safety and health workers worldwide with free COVID-19 resources and safety guidance.
One Nurse’s Experience Highlights Need to Focus on Error Identification and Prevention
Together, ECRI and ISMP PSO create one of the largest patient safety entities in the world with unparalleled and trusted expertise to keep patients safer
ISMP commends the U.S. Food and Drug Administration for requesting that Pfizer revise its current prescribing information and product packaging for vinCRIStine to eliminate syringe administration.
Practitioners should be prepared to take extra precautions with vials of neuromuscular blocking agents without the usual “Warning: Paralyzing Agent” statement required on vial caps and a propofol product that has double the concentration of what is available in the U.S.
ISMP special edition of the ISMP Medication Safety Alert!® acute care newsletter provides details on reports of emerging medication-related events and risks due to the COVID-19 pandemic. The special edition newsletters are being made available for free to the general public as well as subscribers.
ISMP special edition of the ISMP Medication Safety Alert!® acute care newsletter highlights the need to address the stress, anxiety, exhaustion, and depression healthcare workers are facing due to taxing workloads and the constant vigilance required to care for patients during COVID-19 crisis.
ISMP special edition of the acute care newsletter this week provides information on an error-prone dose expression on the label of an unapproved drug, ascorbic acid, that is being used to hasten recovery in COVID-19 patients; it also presents highlights from a Clinician Outreach and Communication Activity (COCA) webinar on the response of two health systems to the pandemic.
Special COVID-19 edition of the ISMP Medication Safety Alert!® acute care newsletter provides tips for safe and efficient use of automated dispensing cabinets (ADCs); and highlights the need for standardizing critical care drug infusions and reports on several recent errors with norepinephrine infusions administered to COVID-19 patients.
ISMP has issued its next special edition of the ISMP Medication Safety Alert!® acute care newsletter, which outlines possible strategies for handling upcoming shortages of smart infusion pumps and dedicated administration sets.
ISMP has developed an online resource page with links to vital COVID-19 safety-related information and tools.
Second special edition of the ISMP Medication Safety Alert!® acute care newsletter explores the use of extension sets to position infusion pumps outside COVID-19 patients’ rooms.
During the COVID-19 pandemic, ISMP is moving to special editions of the ISMP Medication Safety Alert! acute care newsletter that will focus only on information healthcare practitioners may find useful in their response efforts.